TherapeuticsMD, Inc. (TXMD) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 15.26M | 14.45M | 12.17M | 13.46M | 12.51M | 9.93M | 12.15M | 11.82M | 9.19M | 11.8M | 17.44M | 17.28M |
| Cash & Short-Term Investments | 8.42M | 7.48M | 7.12M | 6.07M | 5.75M | 5.06M | 5.05M | 5.23M | 4.34M | 4.33M | 10.17M | 13.73M |
| Cash Only | 8.42M | 7.48M | 7.12M | 6.07M | 5.75M | 5.06M | 5.05M | 5.23M | 4.34M | 4.33M | 10.17M | 13.73M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.21M | 3.52M | 3.67M | 3.74M | 3M | 3.56M | 3.32M | 2.91M | 3.22M | 3.09M | 2.71M | 1.04M |
| Days Sales Outstanding | 418.67 | 370.37 | 434.65 | 322.08 | 750.92 | 474.83 | 524 | 1.19K | 917.56 | 531.02 | -3.25K | 320.58 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -168K | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 3.63M | 3.44M | 1.21M | 3.48M | 3.54M | 1.23M | 3.62M | 3.68M | 1.4M | 4.13M | 3.94M | 1.45M |
| Total Non-Current Assets | 22.32M | 23.21M | 26.5M | 25.04M | 25.72M | 28.9M | 27.4M | 28.3M | 32.9M | 31.51M | 33.05M | 36.41M |
| Property, Plant & Equipment | 5.06M | 5.29M | 5.51M | 5.73M | 5.95M | 6.1M | 6.3M | 6.5M | 6.69M | 6.87M | 7.07M | 7.27M |
| Fixed Asset Turnover | 0.14x | 0.17x | 0.14x | 0.16x | 0.07x | 0.11x | 0.09x | 0.04x | 0.05x | 0.07x | -0.01x | 0.06x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 3.67M | 3.76M | 3.91M | 4.04M | 4.14M | 4.32M | 4.43M | 4.52M | 5.96M | 6.1M | 6.66M | 6.77M |
| Long-Term Investments | 0 | 0 | 14.27M | 0 | 0 | 16.01M | 0 | 0 | 17.86M | 0 | 0 | 19.79M |
| Other Non-Current Assets | 13.59M | 14.16M | 2.8M | 15.27M | 15.64M | 2.46M | 16.67M | 17.28M | 2.39M | 18.54M | 19.32M | 2.59M |
| Total Assets | 37.58M | 37.66M | 38.67M | 38.5M | 38.24M | 38.82M | 39.55M | 40.13M | 42.09M | 43.31M | 50.49M | 53.69M |
| Asset Turnover | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x | 0.01x | 0.01x | 0.01x | 0.01x | -0.00x | 0.01x |
| Asset Growth % | -1.71% | -3% | -2.23% | -4.04% | -9.15% | -10.36% | -21.67% | -25.26% | -29.38% | -52.12% | -62.29% | -63.28% |
| Total Current Liabilities | 4.91M | 4.79M | 4.95M | 4.66M | 4.74M | 5.17M | 5.98M | 5.82M | 6.47M | 6.85M | 14.51M | 14.36M |
| Accounts Payable | 15K | 377K | 263K | 350K | 176K | 258K | 234K | 143K | 139K | 27K | 696K | 1.51M |
| Days Payables Outstanding | 54.28 | - | - | - | - | - | - | - | - | 52.21 | - | - |
| Short-Term Debt | 0 | 0 | 1.07M | 0 | 0 | 1.63M | 0 | 0 | 0 | 0 | 0 | 1.45M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.9M | 4.41M | 3.35M | 2.72M | 2.79M | 3.16M | 2.92M | 3.29M | 4.31M | 3.69M | 8.52M | 8.56M |
| Current Ratio | 3.11x | 3.02x | 2.46x | 2.89x | 2.64x | 1.92x | 2.03x | 2.03x | 1.42x | 1.72x | 1.20x | 1.20x |
| Quick Ratio | 3.11x | 3.02x | 2.46x | 2.89x | 2.64x | 1.92x | 2.03x | 2.06x | 1.42x | 1.72x | 1.20x | 1.20x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 5.7M | 6M | 6.28M | 6.55M | 6.75M | 6.29M | 6.48M | 6.64M | 6.96M | 7.17M | 7.93M | 8.13M |
| Long-Term Debt | 4.82M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 5.12M | 5.41M | 5.72M | 5.96M | 5.54M | 5.78M | 6M | 6.32M | 6.53M | 6.74M | 6.94M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 873K | 873K | 871K | 832K | 795K | 744K | 705K | 637K | 637K | 636K | 1.19M | 1.19M |
| Total Liabilities | 10.61M | 10.78M | 11.23M | 11.21M | 11.5M | 11.45M | 12.46M | 12.46M | 13.42M | 14.02M | 22.44M | 22.49M |
| Total Debt | 4.82M | 5.12M | 6.48M | 6.6M | 6.97M | 7.17M | 7.4M | 7.59M | 7.8M | 8.01M | 8.2M | 8.39M |
| Net Debt | -3.6M | -2.36M | -632K | 535K | 1.23M | 2.12M | 2.35M | 2.36M | 3.46M | 3.68M | -1.96M | -5.34M |
| Debt / Equity | 0.18x | 0.19x | 0.24x | 0.24x | 0.26x | 0.26x | 0.27x | 0.27x | 0.27x | 0.27x | 0.29x | 0.27x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | 17.67x | -159.50x | -391.50x | - | -286.33x | -235.80x | - | -17.64x | -70.70x | -52.64x |
| Total Equity | 26.97M | 26.88M | 27.44M | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M | 28.66M | 29.29M | 28.05M | 31.2M |
| Equity Growth % | 0.87% | -1.8% | 1.29% | -1.37% | -6.71% | -6.55% | -3.42% | -11.31% | -10.49% | -16.66% | 158.11% | 219.68% |
| Book Value per Share | 2.32 | 2.32 | 2.37 | 2.36 | 2.31 | 2.37 | 2.35 | 2.40 | 2.49 | 2.54 | 2.62 | 3.05 |
| Total Shareholders' Equity | 26.97M | 26.88M | 27.44M | 27.29M | 26.74M | 27.37M | 27.09M | 27.67M | 28.66M | 29.29M | 28.05M | 31.2M |
| Common Stock | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K | 11K |
| Retained Earnings | -952.3M | -952.39M | -951.77M | -951.92M | -952.48M | -951.82M | -952.07M | -951.47M | -950.38M | -949.64M | -948.76M | -945.38M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |